Good news for travelers: Arkia resumes popular route | The Jerusalem Post

  good-news-for-travelers-arkia-resumes-popular-route-the-jerusalem-post.html
  Travel and Leisure on Sun, Oct 26th, 2025 by The Jerusalem Post Blogs

The Investigation and Findings

The investigation began in late 2023, after a consumer advocacy group filed a formal complaint alleging that Health Supplements’ marketing was “untruthful and misleading.” The CPA’s compliance team conducted a multi‑phase audit that included a review of 150 product packaging samples, 30 digital advertisements, and 10 sales presentations to distributors. All evidence was cross‑checked against the company’s internal clinical study reports, which the CPA obtained through a freedom‑of‑information request.

The CPA’s findings were damning. In the 2018 “Brain Boost” study, the company failed to meet the stringent criteria set out in the Israeli Food Law, which requires that clinical trials be registered, double‑blinded, and conducted by independent institutions. Moreover, the company’s marketing team cited a 2019 review article that merely summarized the literature without providing primary data, a practice the CPA described as “equivalent to fabricating evidence.” The company’s own spokesperson stated that the “claims were meant to be inspirational rather than literal,” a justification that the CPA deemed insufficient, especially given the health‑related nature of the product.

Legal and Regulatory Context

The CPA’s authority to levy fines stems from the Consumer Protection Law of 2004, which obligates all product manufacturers to provide truthful information and prohibits deceptive practices. In 2021, the Israeli Ministry of Economy adopted a new amendment to the law that increases penalties for repeated violations, setting a ceiling of 15 million shekels for a single offence. Health Supplements’ fine, now the highest in the country for a single company, is a direct application of that amendment.

The CPA’s decision was backed by the Israeli Ministry of Health, which released a statement on Thursday emphasizing that consumer safety must be paramount. “We are taking decisive action to protect the public from misleading claims that could lead to health risks,” the statement read. “Our cooperation with the CPA demonstrates a joint commitment to enforce the highest standards of transparency and accountability.”

Industry Reaction

The reaction from the supplements industry has been mixed. While some manufacturers welcome the crackdown as a fair enforcement of existing standards, others have criticized the CPA’s approach as overly aggressive. In a press release, the National Association of Israeli Health Product Manufacturers (NAIHPM) called the fine “unprecedented and disproportionate.” The association urged the government to revisit the amendment, citing concerns that the increased fines could stifle innovation and disproportionately affect small businesses.

Health Supplements Ltd., meanwhile, has announced its intention to appeal the decision to the Supreme Court. In a statement released on Friday, the company’s legal team argued that the CPA’s interpretation of the clinical trial requirements was too restrictive and that the company had complied with all applicable regulations. “We are confident that the evidence will show that our claims were both truthful and not misleading,” the statement said.

Consumer Impact and Future Outlook

Consumers are at the center of this debate. Last month, a study conducted by the Jerusalem Post’s Consumer Insights Lab revealed that nearly 45 % of Israelis have purchased dietary supplements in the past year, with 62 % reporting that marketing claims influenced their purchase decisions. “This incident highlights a broader issue of transparency in the wellness industry,” said Dr. Maya Cohen, a professor of consumer behavior at Tel Aviv University. “The public deserves accurate, evidence‑based information, especially when it comes to health.”

The CPA has announced a new public awareness campaign aimed at educating consumers about how to evaluate supplement claims. The campaign will feature webinars, a mobile app, and partnerships with retail chains to display warning labels on products that lack verifiable evidence. The CPA’s website will also host a searchable database of approved studies and certifications for manufacturers.

In the long term, industry experts predict that the Health Supplements case will lead to stricter compliance requirements and increased scrutiny of marketing materials. Several international manufacturers operating in Israel have already begun reviewing their own labeling and advertising strategies to ensure alignment with the updated regulatory framework.

The Health Supplements fine is a clear signal that the CPA is willing to take firm action against companies that overstep the boundaries of truthfulness and transparency. While the company’s legal battle will continue, the broader consumer landscape in Israel is poised for a more informed, cautious approach to the burgeoning wellness market.